Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Clinical trial NCT00098722 · COMPLETED
Trial details
- NCT number
- NCT00098722
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-04-01
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.